NU SKIN ENTERPRISES, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
NU SKIN ENTERPRISES, INC. (NUS) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $2.85 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-10
- NU SKIN ENTERPRISES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $381.00K, a 89.72% decline year-over-year.
- NU SKIN ENTERPRISES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $2.47M, a 78.52% decline year-over-year.
- NU SKIN ENTERPRISES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $940.00K, a 39.55% decline year-over-year.
- NU SKIN ENTERPRISES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $8.77M, a 2649.53% increase year-over-year.
- NU SKIN ENTERPRISES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $24.91M, a 51.27% increase from fiscal 2024.
- NU SKIN ENTERPRISES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $16.47M, a 40.61% decline from fiscal 2023.
- NU SKIN ENTERPRISES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $27.73M, a 18.50% decline from fiscal 2022.
- NU SKIN ENTERPRISES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $34.03M, a 33.82% increase from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $381.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $2.85M 10-Q · filed 2026-08-10 | $3.79M derived: sum of 3 quarters · filed 2026-08-10 | $12.56M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $2.47M 10-Q · filed 2026-05-08 | $3.41M derived: sum of 2 quarters · filed 2026-05-08 | $12.18M derived: sum of 3 quarters · filed 2026-05-08 | $15.88M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $940.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $9.71M derived: sum of 2 quarters · filed 2026-02-13 | $13.42M derived: sum of 3 quarters · filed 2026-08-10 | $24.91M 10-K · filed 2026-02-13 |
| 2025-09-30 | $8.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $12.48M derived: sum of 2 quarters · filed 2026-08-10 | $23.97M 10-Q · filed 2025-11-07 | $25.53M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $3.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $15.20M 10-Q · filed 2026-08-10 | $16.76M derived: sum of 3 quarters · filed 2026-08-10 | $17.07M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $11.50M 10-Q · filed 2026-05-08 | $13.05M derived: sum of 2 quarters · filed 2026-05-08 | $13.37M derived: sum of 3 quarters · filed 2026-05-08 | $14.93M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $1.87M derived: sum of 2 quarters · filed 2026-02-13 | $3.44M derived: sum of 3 quarters · filed 2026-02-13 | $16.47M 10-K · filed 2026-02-13 |
| 2024-09-30 | $319.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.88M derived: sum of 2 quarters · filed 2025-11-07 | $14.91M 10-Q · filed 2025-11-07 | $28.29M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $14.60M 10-Q · filed 2025-08-08 | $27.97M derived: sum of 3 quarters · filed 2026-02-13 | $28.27M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $13.03M 10-Q · filed 2025-05-09 | $26.41M derived: sum of 2 quarters · filed 2026-02-13 | $26.71M derived: sum of 3 quarters · filed 2026-02-13 | $32.78M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $13.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $13.68M derived: sum of 2 quarters · filed 2026-02-13 | $19.75M derived: sum of 3 quarters · filed 2026-02-13 | $27.73M 10-K · filed 2026-02-13 |
| 2023-09-30 | $299.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $6.37M derived: sum of 2 quarters · filed 2024-11-08 | $14.35M 10-Q · filed 2024-11-08 | $19.59M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $6.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $14.05M 10-Q · filed 2024-08-09 | $19.29M derived: sum of 3 quarters · filed 2025-02-14 | $22.29M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $7.98M 10-Q · filed 2024-05-09 | $13.22M derived: sum of 2 quarters · filed 2025-02-14 | $16.21M derived: sum of 3 quarters · filed 2025-02-14 | $18.28M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $5.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $8.23M derived: sum of 2 quarters · filed 2025-02-14 | $10.30M derived: sum of 3 quarters · filed 2025-02-14 | $34.03M 10-K · filed 2025-02-14 |
| 2022-09-30 | $2.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $5.05M derived: sum of 2 quarters · filed 2023-11-02 | $28.79M 10-Q · filed 2023-11-02 | $35.09M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $2.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $25.79M 10-Q · filed 2023-08-02 | $32.10M derived: sum of 3 quarters · filed 2024-02-15 | $37.49M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $23.73M 10-Q · filed 2023-05-04 | $30.04M derived: sum of 2 quarters · filed 2024-02-15 | $35.43M derived: sum of 3 quarters · filed 2024-02-15 | $38.27M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $6.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $11.70M derived: sum of 2 quarters · filed 2024-02-15 | $14.54M derived: sum of 3 quarters · filed 2024-02-15 | $25.43M 10-K · filed 2024-02-15 |
| 2021-09-30 | $5.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $8.23M derived: sum of 2 quarters · filed 2022-11-03 | $19.12M 10-Q · filed 2022-11-03 | $39.27M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $2.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $13.73M 10-Q · filed 2022-08-05 | $33.88M derived: sum of 3 quarters · filed 2023-02-16 | $65.21M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $10.89M 10-Q · filed 2022-05-05 | $31.04M derived: sum of 2 quarters · filed 2023-02-16 | $62.38M derived: sum of 3 quarters · filed 2023-02-16 | $71.73M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $20.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $51.48M derived: sum of 2 quarters · filed 2023-02-16 | $60.84M derived: sum of 3 quarters · filed 2023-02-16 | $82.66M 10-K · filed 2023-02-16 |
| 2020-09-30 | $31.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $40.69M derived: sum of 2 quarters · filed 2021-11-04 | $62.51M 10-Q · filed 2021-11-04 | $96.89M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $9.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $31.18M 10-Q · filed 2021-08-05 | $65.55M derived: sum of 3 quarters · filed 2022-02-16 | $75.09M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $21.82M 10-Q · filed 2021-05-05 | $56.20M derived: sum of 2 quarters · filed 2022-02-16 | $65.74M derived: sum of 3 quarters · filed 2022-02-16 | $77.62M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $34.38M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $43.92M derived: sum of 2 quarters · filed 2022-02-16 | $55.80M derived: sum of 3 quarters · filed 2022-02-16 | $184.50M 10-K · filed 2022-02-16 |
| 2019-09-30 | $9.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $21.42M derived: sum of 2 quarters · filed 2020-11-05 | $150.13M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $11.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $140.59M 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $128.70M 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |